Challapalli, AWatkins, SCogill, GStewart, GEllis, SSykes, ANobes, JYip, KBarthakur, UBoard, RGadve, AO'Toole, LKent, CMackenzie, JPapa, SFusi, AFife, K2023-10-042023-10-042022-03-17Challapalli A, Watkins S, Cogill G, Stewart G, Ellis S, Sykes A, Nobes J, Yip K, Barthakur U, Board R, Gadve A, O'Toole L, Kent C, Mackenzie J, Papa S, Fusi A, Fife K. Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e590-e592. doi: 10.1111/jdv.18082. Epub 2022 Mar 24.0926-99591468-308310.1111/jdv.1808235298050http://hdl.handle.net/20.500.14200/2418No abstract available.enOncology. Pathology.DermatologyCemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient SchemeCorrespondence